0001055726-22-000001.txt : 20220105 0001055726-22-000001.hdr.sgml : 20220105 20220105160405 ACCESSION NUMBER: 0001055726-22-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220105 DATE AS OF CHANGE: 20220105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zoth Lota S. CENTRAL INDEX KEY: 0001278219 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14888 FILM NUMBER: 22511084 MAIL ADDRESS: STREET 1: 334 CR 692 CITY: BUFFALO GAP STATE: TX ZIP: 79508 FORMER NAME: FORMER CONFORMED NAME: ZOTH LOTA S DATE OF NAME CHANGE: 20040130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001055726 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330969592 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584103134 MAIL ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP DATE OF NAME CHANGE: 20050404 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP DATE OF NAME CHANGE: 20011116 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD DATE OF NAME CHANGE: 19980213 4 1 wf-form4_164141662488992.xml FORM 4 X0306 4 2022-01-03 0 0001055726 INOVIO PHARMACEUTICALS, INC. INO 0001278219 Zoth Lota S. 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 1 0 0 0 Common Stock 2022-01-03 4 M 0 4090 A 25977 D Common Stock 2022-01-05 4 S 0 961 5.01 D 25016 D Restricted Stock Unit 2022-01-03 4 M 0 4090 0 D Common Stock 4090.0 0 D Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,270 restricted stock units is as follows: 4,090 shares vested on January 3, 2020; 4,090 shares vested on January 3, 2021; 4,090 shares vested on January 3, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. /s/ Lota Zoth 2022-01-05